Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Calcified Tissue International
Metadata
Title
Osteopontin Deficiency Increases Mineral Content and Mineral Crystallinity in Mouse Bone
Authors
A.L. Boskey
L. Spevak
E. Paschalis
S.B. Doty
M.D. McKee
Publication date
01-08-2002
Publisher
Springer-Verlag
Published in
Calcified Tissue International / Issue 2/2002
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-001-1121-z

Other articles of this Issue 2/2002

Calcified Tissue International 2/2002 Go to the issue

OriginalPaper

Is it Necessary to Screen for Celiac Disease in Postmenopausal Osteoporotic Women?

OriginalPaper

Fourier Transform Infrared Microspectroscopic Investigation of the Organic and Mineral Constituents of Peritubular Dentin: A Horse Study

OriginalPaper

Assessment of the Bone Status of Nigerian Children and Adolescents with Sickle Cell Disease Using Calcaneal Ultrasound and Serum Markers of Bone Metabolism

OriginalPaper

Ultrastructure of Forming Enamel in Mouse Bearing a Transgene That Disrupts the Amelogenin Self-Assembly Domains

OriginalPaper

Conditional Gene Inactivation Using cre Recombinase

OriginalPaper

Regional Bone Loss After Orthotopic Liver Transplantation in Inbred Rats: The Role of Hepatic Denervation

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits